Jie Luo, MD
Interventional Pain Medicine · Salt Lake City, UTNPI 1912240391
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,809 of the $8,487 with a category attached, or 68.4%. 16 manufacturers reported payments, led by Boston Scientific at 34.4% of the total. Reporting peaked in 2022 at $3,628 and has fallen 62.4% since, to $1,363 in 2025.
Across 209 payments — averaging $40.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$3K
- Relievant Medsystems, Inc.$1K
- Nevro Corp.$286
- Stryker$284
- SPR Therapeutics, Inc$241
- plus $526 from 10 others
Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$16
What the payments were for
- Travel & lodging$2,67832%
- Food & beverage$5,80968%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 89 | $2,919 |
| Medtronic(2 entities) | 79 | $2,792 |
| Relievant Medsystems, Inc. | 6 | $1,440 |
| Nevro Corp. | 6 | $286 |
| Stryker | 8 | $284 |
| SPR Therapeutics, Inc | 2 | $241 |
| Biotronik NRO, Inc. | 3 | $113 |
| AbbVie | 5 | $110 |
| Abbott | 2 | $94 |
| Nalu Medical, Inc. | 2 | $55 |
| Averitas Pharma Inc. | 1 | $46 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Avanos Medical | 1 | $25 |
| Saluda Medical Americas, Inc. | 1 | $20 |
| MML US, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,487 in reported general payments places this provider in the 60th percentile of 26 interventional pain medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $3,308 |
| Lidocaine | 11 | $2,426 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $2,067 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 73 | $1,848 |
| Gabapentin | 65 | $840 |
| Pregabalin | 42 | $657 |
| Methylprednisolone | 46 | $375 |
| Duloxetine Hcl | 29 | $325 |
| Tramadol Hcl | 49 | $214 |
| Diazepam | 27 | $138 |
| Tizanidine Hcl | 13 | $88 |
| Meloxicam | 15 | $20 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Salt Lake City
- David ByrdSalt Lake City$7K
- John HongSalt Lake City$6K
- Richard GlinesSalt Lake City$4K
- Bryan HoelzerVineyard$718K
- Nathan ClementsSaint George$29K
- Rick ObraySt George$23K
- Brian RichardsonLogan$19K
- Alex NelsonMurray$17K
- Steven LarsenSaint George$14K
- J Riley StringhamProvo$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.